FINISHED DOSAGE FORMULATIONS
Drug : AVAPRO
Dosage Form : TABLET; ORAL
Application Number : 20757
Country : US
Patented : No
Drug : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 213473
Country : US
Patented : No
ESOMEPRAZOLE MAGNESIUM; NAPROXEN
Drug : NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 204206
Country : US
Patented : No
Drug : SIROLIMUS
Dosage Form : TABLET; ORAL
Application Number : 201578
Country : US
Patented : No
Drug : METOPROLOL SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 76862
Country : US
Patented : No
Drug : VALSARTAN
Dosage Form : TABLET; ORAL
Application Number : 91367
Country : US
Patented : No
Drug : ESOMEPRAZOLE MAGNESIUM
Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL
Application Number : 208333
Country : US
Patented : No
CEFADROXIL/CEFADROXIL HEMIHYDRATE
Drug : CEFADROXIL
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 65278
Country : US
Patented : No
CLINDAMYCIN PALMITATE HYDROCHLORIDE
Drug : CLINDAMYCIN PALMITATE HYDROCHLORIDE
Dosage Form : FOR SOLUTION; ORAL
Application Number : 202409
Country : US
Patented : No
Drug : BANZEL
Dosage Form : TABLET; ORAL
Application Number : 21911
Country : US
Patented : No
POLOXAMER 188
Route : ORAL
CAS :
UNII : LQA7B6G8JG
Potency Amount : 1.5
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 188
Route : INTRAMUSCULAR
CAS : 691397-13-4
UNII : LQA7B6G8JG
Potency Amount : 0.2
Potency Unit : %W/V
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 188
Route : INTRAVENOUS
CAS : 691397-13-4
UNII : LQA7B6G8JG
Potency Amount : 0.6
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 188
Route : INTRAVENOUS
CAS : 691397-13-4
UNII : LQA7B6G8JG
Potency Amount : 0.22
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 188
Route : OPHTHALMIC
CAS : 691397-13-4
UNII : LQA7B6G8JG
Potency Amount : 0.1
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 188
Route : OPHTHALMIC
CAS : 691397-13-4
UNII : LQA7B6G8JG
Potency Amount : 0.1
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 188
Route : ORAL
CAS : 691397-13-4
UNII : LQA7B6G8JG
Potency Amount : 10
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 188
Route : ORAL
CAS : 691397-13-4
UNII : LQA7B6G8JG
Potency Amount : 3.18
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 188
Route : ORAL
CAS : 691397-13-4
UNII : LQA7B6G8JG
Potency Amount : 4
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 188
Route : ORAL
CAS : 691397-13-4
UNII : LQA7B6G8JG
Potency Amount : 0.25
Potency Unit : MG/1ML
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
EXCIPIENTS BY APPLICATIONS
Application : Parenteral
Excipient Details : Poloxamer 188 is used as a solubilizer, emulsifier, stabilizer in parenteral, OSDs & topical formulations such as creams, gels & lotions.
Pharmacopoeia Ref : ChP/USP/EP
Technical Specs : Oxyethylene unit: 75%-85%, Oxypropylene unit: 25%-30%
Ingredient(s) : Poloxamer 188
MARKET PLACE